Valentin Fuster

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Valentin Fuster
Valentin Fuster on Mount Sinai campus, July 2013.jpg
Valentín Fuster on Mount Sinai's Manhattan campus, July 2013.
Born 1943
Barcelona, (Spain)
Occupation Cardiologist

Valentín Fuster is a Spanish cardiologist – the only cardiologist to receive the two highest gold medal awards and all four major research awards from the world's four major cardiovascular organizations: The Distinguished Researcher Award (Interamerican Society of Cardiology, 2005 and 2009), Andreas Gruntzig Scientific Award[1] and Gold Medal Award (European Society of Cardiology, 1992-2007 respectively), Gold Medal Award and Distinguished Scientist (American Heart Association, 2001 and 2003 respectively), and the Distinguished Scientist Award (American College of Cardiology, 1993).[2] In November 2012, Dr. Fuster received the highest honor given by the American Heart Association, the Research Achievement Award.[3] Dr. Fuster has ranked among the Top Doctors in the US for the past 13 years and is considered in the top 1% of physicians in the United States by Castle-Connolly.[4]

Life and career[edit]

Dr. Fuster serves as Physician-in-Chief, as well as Director of Mount Sinai Heart, The Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai.[2] Dr. Fuster was the President of Science and is now the General Director of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, (Spain).[5]

Dr. Fuster will take over as editor in chief at the Journal of the American College of Cardiology in 2014.[6] Among the seemingly countless positions of distinction that he holds are Past President of the American Heart Association,[7] Past President of the World Heart Federation, Member of the Institute of Medicine of the National Academy of Sciences[8] where he serves as Chair of the committee on Preventing the Global Epidemic of Cardiovascular Disease,[9] former member of the National Heart, Lung, and Blood Institute Advisory Council,[10] and former Chairman of the Fellowship Training Directors Program of the American College of Cardiology. Thirty distinguished universities throughout the world have granted him Honorary Doctorate Degrees.[2]

Fuster was born in Barcelona, (Spain) after the end of the Spanish Civil War. His early aptitude for tennis let him to compete at a national level, and it was through tennis that he met his future mentor – Pedro Farreras, the author of the standard Spanish textbook of medicine. After Farreras suffered a heart attack at age 45, he encouraged Fuster to study cardiology. Fuster pursued his degree at the University of Barcelona, graduating with a MD in 1967, first in his class. He then completed an internship at the Hospital Clinic in Barcelona. Encouraged by his tutor, he then went to the University of Edinburgh Medical School for his PhD on the role of platelets in myocardial infarction.[11]

While completing his PhD in Edinburgh, Fuster served as a Research Fellow in Cardiology at the Royal Infirmary of Edinburgh from 1968 to 1971.[11] After completing his PhD in 1971 from the University of Edinburgh Medical School, Dr. Fuster spent several years at the Mayo Clinic, first as a resident and later as Professor of Medicine and Consultant in Cardiology.[11] In 1981, he came to Mount Sinai School of Medicine as head of Cardiology. From 1991 to 1994, he was Mallinckrodt Professor of Medicine at Harvard Medical School and Chief of Cardiology at the Massachusetts General Hospital. He returned to Mount Sinai in 1994 as Director of the Zena and Michael A. Wiener Cardiovascular Institute and in 2006, he was named the Director of Mount Sinai Heart.[12]

In his down time, Dr. Fuster is an avid cyclist - he has tackled the stages of the Tour de France and the Giro D'Italia, two of the most grueling road races in the world. He has ridden the Col du Tourmalet, a Tour de France climb on the highest mountain pass in the central Pyrenees, multiple times, as well as the Col d'Aubisque, another climb in the Pyrenees.[13]

Positions and distinctions[edit]

  • The Mount Sinai Medical Center as Director of Mount Sinai Heart
  • The Zena and Michael A. Wiener Cardiovascular Institute
  • The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health.
  • The Richard Gorlin, MD/Heart Research Foundation Professor, Mount Sinai School of Medicine.
  • Past President of the American Heart Association
  • Past President of the World Heart Federation
  • Member, the Institute of Medicine of the National Academy of Sciences
  • Past member, the National Heart, Lung and Blood Institute Advisory Council
  • Former Chairman, the Fellowship Training Directors Program of the American College of Cardiology
  • Member, Scientific Advisory Board of Vasogen, Inc.[14]
  • General Director of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, Spain.
  • Member, La Sociedad Mexicana para el Estudio de la Hipertension Arterial
  • President, Paul Dudley White Society
  • Chairman, NHLBI Review Committee of the CV Program

Honors and Awards[edit]

Partial list contains 12 of over 150 awards and honors:

  • 1993 Distinguished Scientist Award, American College of Cardiology[15]
  • 1996 Principe de Asturias Award of Science and Technology (the highest award to Spanish speaking scientists, given by the son of the King of Spain), Fundacion Principe de Asturias, Oviedo, Spain [16]
  • 2001 James B. Herrick Award, Council of Clinical Cardiology of the American Heart Association[17]
  • 1992 Andreas Gruntzig Award of the International Society of Interventionalists(Paris)[1]
  • Lewis A. Conner Memorial Award, American Heart Association [15]
  • 2005, 2009 Distinguished Researcher Award, Interamerican Society of Cardiology[18]
  • 2001 Gold Medal Award, American Heart Association[2]
  • 2007 Gold Medal Award, European Society of Cardiology, Vienna, Austria[2]
  • 2008 Polzer Prize, European Academy of Science and Arts [19]
  • 2009 ACC Distinguished Teacher Award, Orlando, FL[2]
  • 2009 International Arrigo Recordati Award for his Scientific Achievement [20]
  • 2011 The LeFoulon Delalande Grand Prize, Institute of France, Paris, France [21]
  • 2012 AHA Research Achievement Award, Los Angeles, CA[3]

Scientific Investigator[edit]

Research Focus and Recognition[edit]

Dr. Fuster is the recipient of two major ongoing NIH grants. To date, he has published more than 900 Pubmed articles on the subjects of coronary artery disease, atherosclerosis and thrombosis,[22] and he has become the lead Editor of two major textbooks on cardiology, “The Heart” (previously edited by Dr. J. Willis Hurst[23])and “Atherothrombosis and Coronary Artery Disease” (with Dr. Eric Topol and Dr. Elizabeth Nabel[24]). Dr. Fuster is a former Editor-in-Chief of Nature Reviews Cardiology[25] and he is the Editor of the new “AHA Guidelines and Scientific Statements Handbook”,[26] which compiles all the latest information. In addition, Fuster has received the Lewis A. Conner Memorial Award by the American Heart Association, the James B. Herrick Achievement Award[21] from the Council of Clinical Cardiology of the American Heart Association, and the 1996 Principe de Asturias Award[27] of Science and Technology (the highest award given to Spanish-speaking scientists). In 2008, Dr. Fuster received the Kurt Polzer Cardiovascular Award from the European Academy of Sciences and Arts.[28] In 2009, he received the Distinguished Teacher Award of the American College of Cardiology and then later that year, the prestigious International Arigo Recordati Award[29] for his Scientific Achievement in the development of Cardiovascular Imaging. Finally this June, Dr. Fuster received the Lefoulon Delalande Grand Prix, from the Institute of France, which is considered the most prestigious award given in the field of cardiovascular research. In March 2012, during the ACC National Meeting, Dr. Fuster was honored as one of the two American “Legends in Cardiovascular Medicine.[30]

Complex Cardiology[edit]

Dr. Fuster handles some of the most complex cases in New York,[31] and is sought by patients from around the world. Since 1992, Fuster has been listed among the Best Doctors in America and New York.[32] Fuster made news in 2006 when he managed a patient who underwent successful combined heart and lung transplant, which New York Magazine named one of the year’s "11 medical marvels".[33]

Contributions in translational medicine[edit]

  1. The original understanding of a major role played by platelets in atherothrombotic disease, based on long-term experiments in pigs with a deficiency of von Willebrand factor, severe platelet dysfunction, and resistance to atherothrombosis[34][35]
  2. The first demonstration of the role played by platelets in CABG occlusion and prevention by aspirin, findings based on platelet imaging in dogs and on our subsequent definitive trial in humans (first trial of aspirin on CAD)[36][37]
  3. The first demonstration in humans that coronary plaque rupture occurs in plaques that paradoxically are small and angiographically silent, an angiographic finding that explains the unpredictability of events and led to new diagnostic MRI technology on identification and characterization of arterial plaques at autopsy [38][39][40][41]
  4. The first demonstration that a critical substrate of thrombosis following plaque rupture is a lipid-rich plaque (vulnerable plaque) with a high density of macrophages undergoing apoptotic death with a release of tissue factor, findings which are based on a sequence of experimental and clinical studies, in part based on MRI and PET technology[42]
  5. The first identification and characterization by new MRI technology (black-blood)of the vulnerable/high-risk plaques and reversibility by statins, findings based on a sequence of animal and human studies that led to the recent interest in cardiovascular MR imaging [43]
  6. The first demonstration in vivo of an important role of HDL in reversing lipid and macrophange-rich plaques, a finding based on the infusion of HDL in cholesterol-fed rabbits (and recently supported by others in CAD patients) and in cross-transplantation of the atherosclerotic aorta from transgenic mice with low HDL into mice with high HDL[44][45]
  7. The first demonstration of rapamycin as a powerful inhibitor of post-injury smooth muscle cell migration/proliferation/extra-cellular matric development, which are findings first based on a series of in vitro studies, then documented in pigs and recently confirmed by others in humans by the prevention of restenosis with drug-eluted stents.[46]
  8. The first demonstration of the great potency of antithrombins in the prevention of thrombosis in experimental animals, which has also been demonstrated recently in humans by his colleagues in the RE-LY trial on atrial fibrillation with the prevention of arterial embolism in those given oral antithrombins[47]
  9. Based on MRI technology, demonstration in animals and humans of the development of neovascularization in the adventitia and media with the purpose to remove oxidized LDL-C from the intima, specifically when LDL-C in blood decreases with statins[48][49]
  10. The documentation by MRI technology in animals and of histopathology in humans, that neovasculature, by leaking red blood cells into the interstitium induces an inflammatory reaction that predisposes to the rupture of the internal elastic lamina and eventually to plaque rupture and thrombotic occlusion[49][50]

Significant Contributions to Large Clinical Trials, Global Health and Education[edit]

As a result of this vocation and the clear social need to promote healthy habits, Dr. Fuster has created the SHE Foundation (Science, Health and Education) with the aim of improving total health in the population, especially young people.[2]

SHE Foundation[edit]

“After a lifetime devoted to medicine and research, Valentin Fuster, MD, PhD is convinced that a change in the population’s lifestyle is the only way to avoid the spread of cardiovascular diseases, which are a real epidemic and the main cause of death in the world. “Faced with this evidence and based on the experience gained over his career, Valentin Fuster, MD, PhD promoted the creation of SHE, a non-profit foundation that, while focused on basic and clinical research (Science), is aimed at promoting healthy habits (Health) through communication and Education of the population. “With this goal, the SHE Foundation devotes its efforts to creating a frame of reference for what an education in health means and involves, stressing the acquirement of healthy habits from childhood in order to promote a world in which children, young people and adults have the ability to act positively towards their health.”[51]

Sesame Workshop[edit]

“Valentin Fuster, MD, PhD, Director of Mount Sinai Heart, is the inspiration for a Muppet doctor on Barrio Sésamo: Monstrous Supersanos, the Spanish version of Sesame Street which debuted on Spain's Antena 3 just last month. The character named "Dr. Valentin Ruster" is helping to educate children to lead healthier lifestyles through exercise and healthy diet. “Dr. Fuster serves as an international advisor on Sesame Workshop's Global Health Initiative. Cardiovascular disease is the leading cause of death around the world, and the goal of the initiative is to measure health improvements in children and build global partnerships to address their critical health issues. In fact, many studies show that childhood obesity leads to cardiovascular disease, thru an increase in cardiovascular disease risk factors including high blood pressure, high cholesterol, etc. Globally, in 2010, the number of overweight children under the age of five is estimated to be over 42 million. Sesame Workshop, which has been creating specific content on healthy habits for young children and their families for almost a decade, is now exploring opportunities with Dr. Fuster to extend its initiative in the United States. “Dr. Fuster first joined forces with Sesame Workshop in 2006 to collaborate with Plaza Sesamo, the Latin American version of Sesame Street, to promote cardiovascular health and well-being in Colombia. The series there encourages children, parents, teachers, and caregivers in making informed nutritional and lifestyle decisions based on educational television content, community outreach, and evidence-based research."[52]

FREEDOM Trial[edit]

The FREEDOM trial, involving 150 institutions around the world is the largest funded study (NIH) in diabetes and is led by Dr. Fuster. It aimed at defining the optimal revascularization strategy for diabetic patients with multivessel coronary disease.[53][54] The striking benefit of surgical revascularization versus stenting represents unique breakthroughs in the cardiovascular field as presented in the 2012 AHA Scientific Sessions and simultaneously published in the NEJM.[55]

Polypill[edit]

“The prevention of cardiovascular disease is hindered by several factors, including wide variability in the pattern of prescription among physicians, limited access to expensive drugs in emerging countries, and poor adherence to medication. The use of fixed dose drug combinations (polypill) has been recommended to improve accessibility and adherence to treatment. The CNIC, working in a private-public partnership with Ferrer International, has devised a fixed dose combination for secondary prevention. The CNIC-Ferrer polypill project is led by Valentín Fuster and is coordinated by the Translational Research Platform.”.[56]

Promoting Cardiovascular Health Worldwide[edit]

This is a report recently released by the Institute of Medicine of The National Academy of Science, under the sponsorship of the National Heart, Lung, and Blood Institute. It was the result of deliberations of a 130member committee of experts chaired by Dr. Fuster and made available to all governments of the world in order to initiate and/or contribute to global health policy for chronic diseases.[57]

Promoting Cardiovascular Health in Children[edit]

This large scale initiative was carried out in Colombia and Spain under Dr. Fuster's leadership. In Colombia, a randomized control was conducted to assess the impact in children three to six years of age (a time of behavioral development) of knowledge, attitude and habits regarding healthy eating and living an active lifestyle. Children in the 40-hour intervention group showed a significantly larger increase in total score compared to that in the control group. Three years later, children showed a further increase in total score. This finding will be published in the American Journal of Medicine.[58]

The project's results have led to its expansion into about 25,000 children in Colombia and 20,000 children in Spain. In Spain's program, a new muppet character was recently created, inspired by Dr. Fuster. The character and his storyline are aimed at educating the children of "Barrio Sesame" about their hearts and bodies. The two country project will be long running in order to prove tat the interventions at such an early age have an impact on adult behavior. The participants will be evaluated each year.

Promoting Cardiovascular Health in Adults of Middle-Income Countries[edit]

Health in adults of middle-income countries can be reflected by a pilot project directed by Dr. Fuster on the island of Granada in the Caribbean, which has a population of 100,000 people. He is assembling groups of 10 people, with a cardiovascular risk factor profile in an Alcoholics Anonymous format that uses peer pressure to help participants adopt healthier behaviors.[59] This project is based on a successful risk factor profile pilot study carried out in nearly 3,000 Grenadians and on a recent, also successful, 10-person group study now finishing in a small town in Spain.

Promoting Cardiovascular Health in Adults of Low-Income Countries[edit]

Exemplified by an NIH grant awarded to Dr. Fuster as a principal investigator, the objective of this project is to address the issue of hypertension in Kenya. Hypertension is the leading global risk factor for mortality, and the global cost of sub-optimal blood pressure is estimated to be very high. The project is demonstrating the effective impact of combining the "human factor" and "high technology." That is, a small portion of the 100,000 population of two town districts - Turbo and Mosoriot - are being trained through automatic machines, to take the blood pressure measurement of their respective neighborhood; the values are then registered and centralized by the use of "intelligent phones." Hopefully, such an approach will be transferable to other cities and countries.

Research & Educational AHA-FORUM[edit]

A national program developed by Dr. Fuster when he was President of the American Heart Association, having two objectives in mind: 1) To engage potential young researchers with volunteer senior investigators of the AHA, offering as such, free tutorship or mentorship; the success stories of this approach are many. 2) To reinvigorate the Junior-Senior investigator relationships through and annual meeting, the Saturday preceding the Scientific Sessions of the AHA; the yearly attendance counts in the hundreds.

Clinical & Educational AHA "Fellows Society of the Greater New York"[edit]

A regional program developed by Dr. Fuster when he was President of the AHA, New York Cit (2003-2004), the purpose being two-fold: 1)To educate fellows or young cardiologists in training in the greater New York area - including Connecticut, New Jersey, Long Island and the five Boroughs of NYC - about American Heart Association programs and activities. 2) To provide a forum for professional interaction, problem solving and discussion of professional issues among the cardiology fellows. Such a successful program, it is now being extended to other regions of the country including Chicago, Boston, Los Angeles, and Philadelphia.

CNIC, or "Centro Nacional de Investigaciones Cardiovasculares"[edit]

The Spanish Public research institute supported by the Government and by a core group of the most important Spanish private companies (Pro-CNIC Foundation).[60][61] Under Dr. Fuster's leadership, these last five years have been crucial in two aspects: 1)For the development of an outstanding center of research, earning the prestigious award "Severo Ochoa Center of Excellence", as determined by three international committees. 2) The creation of an ambitious and comprehensive training program, the "CNIC-JOVEN," composed of 15 different programs aimed to identify and train the best and brightest talents for cardiovascular research, starting from levels of secondary education forward.

High Risk Plaque (HRP) Bioimage Initiative[edit]

With Dr. Fuster as a principal investigator, is aimed: a) to discover the role of multi-modality imaging (five technologies) in predicting subclinical disease, b) to identify the most cost-effective imaging technology for potential use in low and medium economy countries, and c) to evaluate whether subclinical isease can motivate the individual to modify his/her lifestyle. The project is successfully involving 6,000 Americans (Chicago and Florida areas) and 8,000 Europeans (Madrid and Zaragoza, Spain)[62]

Author & Editor[edit]

Books[edit]

Editorial[edit]

References[edit]

  1. ^ a b "Dr. Valentin Fuster Honored with Grand Prix Award", TheHeart retrieved March 21, 2013
  2. ^ a b c d e f g "Doctor Profile", Mount Sinai Hospital retrieved March 13, 2013
  3. ^ a b "New York City scientist wins American Heart Association award for major additions to knowledge of artery disease process, treatments", American Heart Association retrieved March 12, 2013
  4. ^ Profile - Valentin Fuster, Castle Connolly Top Doctors retrieved April 2, 2013
  5. ^ "Valentin Fuster Carulla", CNIC retrieved March 12, 2013
  6. ^ http://www.theheart.org/article/1569917.do
  7. ^ Fuster, Valentin (2006). "Passing the Torch". Journal of the American Heart Association 100 (2): 106. doi:10.1161/01.CIR.100.2.106. 
  8. ^ Wood, Shelley (2000). "Valentin Fuster Elected to Institute of Medicine". HeartWire. 
  9. ^ "Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries", CNIC retrieved March 12, 2013
  10. ^ "Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report", NHLBI retrieved March 12, 2013
  11. ^ a b c "VALENTIN FUSTER, M.D., PH.D. Curriculum Vitae". Mount Sinai. Retrieved 17 August 2013. 
  12. ^ "Spotlight: Dr Valentin Fuster, MD, PhD, FESC". Journal of the American Heart Association. 2007. 
  13. ^ "Live what you advocate: The exercise habits of busy cardiologiests", theHeart.org retrieved March 12, 2013
  14. ^ BusinessWeek retrieved April 29, 2008
  15. ^ a b "Previous Years Distinguished Scientists", American Heart Association retrieved March 21, 2013
  16. ^ "Valentin Fuster - Technical & Scientific Research 1996", Fundacion Principe de Asturias retrieved March 21, 2013
  17. ^ "James B. Herrick Award for Outstanding Achievement in Clinical Cardiology", American Heart Association retrieved March 21, 2013
  18. ^ "IASC Presents Dr. Valentin Fuster with the Distinguished Researcher Award", Newswise retrieved March 21, 2013
  19. ^ "Valentin Fuster Biography", CNIC retrieved March 13, 2013
  20. ^ "2009 Prize Winner", The International Prize for Scientific Research retrieved March 21, 2013
  21. ^ a b "James B. Herrick Award for Outstanding Achievement in Clinical Cardiology", theHeart.org retrieved March 12, 2013
  22. ^ "Search Results" retrieved March 12, 2013
  23. ^ "Hurst's the Heart Manual of Cardiology, Thirteenth Edition" retrieved March 12, 2013
  24. ^ "Atherothrombosis and Coronary Artery Disease" retrieved March 12, 2013
  25. ^ "Brief biographical summary of PhD recipients" retrieved March 12, 2013
  26. ^ "The AHA Guidelines and Scientific Statements Handbook" retrieved March 12, 2013
  27. ^ "Prince of Austrias Award For Technical & Scientific Research 1996", Fundacion Principe de Asturias retrieved March 12, 2013
  28. ^ "Valentin Fuster, MD, PhD Receives Distinguished Teacher Award from American College of Cardiology", Mount Sinai retrieved March 12, 2013
  29. ^ "The International Prize for Scientific Research Arrigo Recordati", 2009 Prize Winner retrieved March 12, 2013
  30. ^ "Valentin Fuster named 'Legend of Cardiovascular Medicine' by the American College of Cardiology" retrieved March 12, 2013
  31. ^ "A Better Heart Without Surgery - Stephanie's Valve Replacement Story" retrieved March 12, 2013
  32. ^ "Valentin Fuster, MD/PHD" retrieved March 12, 2013
  33. ^ Rosenblum, Emma (2006). "Medical Marvel #9". New York Magazine. 
  34. ^ Fuster, Valentin; Bowie, E. J. Walter; Lewis, Jon C.; Fass, David N.; Owen, Charles A.; Brown, Arnold L. (1978). "Resistance to Arteriosclerosis in Pigs with von Willebrand's Disease". Journal of Clinical Investigation 61 (3): 722. doi:10.1172/JCI108985. PMC 372586. PMID 305924. 
  35. ^ . PMID 6814782.  Missing or empty |title= (help)
  36. ^ . PMID 315282.  Missing or empty |title= (help)
  37. ^ Chesebro, James H.; Fuster, Valentin; Elveback, Lila R.; Clements, Ian P.; Smith, Hugh C.; Holmes, David R.; Bardsley, William T.; Pluth, James R.; Wallace, Robert B.; Puga, Francisco J.; Orszulak, Thomas A.; Piehler, Jeffrey M.; Danielson, Gordon K.; Schaff, Hartzell V.; Frye, Robert L. (1984). "Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations". New England Journal of Medicine 310 (4): 209. doi:10.1056/NEJM198401263100401. PMID 6361561. 
  38. ^ . PMID 3379219.  Missing or empty |title= (help)
  39. ^ Epstein, Franklin H.; Fuster, Valentin; Badimon, Lina; Badimon, Juan J.; Chesebro, James H. (1992). "The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes". New England Journal of Medicine 326 (4): 242. doi:10.1056/NEJM199201233260406. PMID 1727977. 
  40. ^ Epstein, Franklin H.; Fuster, Valentin; Badimon, Lina; Badimon, Juan J.; Chesebro, James H. (1992). "The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes". New England Journal of Medicine 326 (5): 310. doi:10.1056/NEJM199201303260506. PMID 1728735. 
  41. ^ . PMID 8918520.  Missing or empty |title= (help)
  42. ^ . PMID 7718033.  Missing or empty |title= (help)
  43. ^ . PMID 11509446.  Missing or empty |title= (help)
  44. ^ Badimon, J J; Badimon, L; Fuster, V (1990). "Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit". Journal of Clinical Investigation 85 (4): 1234. doi:10.1172/JCI114558. PMID 2318976. 
  45. ^ Ibanez, Borja; Vilahur, Gemma; Cimmino, Giovanni; Speidl, Walter S.; Pinero, Antonio; Choi, Brian G.; Zafar, M. Urooj; Santos-Gallego, Carlos G.; Krause, Brian; Badimon, Lina; Fuster, Valentin; Badimon, Juan J. (2008). "Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-IMilano (ETC-216) Administration". Journal of the American College of Cardiology 51 (11): 1104. doi:10.1016/j.jacc.2007.09.071. PMID 18342230. 
  46. ^ Poon, Michael; Badimon, Juan Jose; Fuster, Valentin (2002). "Viewpoint Overcoming restenosis with sirolimus: From alphabet soup to clinical reality". The Lancet 359 (9306): 619. doi:10.1016/S0140-6736(02)07751-6. 
  47. ^ . PMID 2401076.  Missing or empty |title= (help)
  48. ^ . PMID 12460866.  Missing or empty |title= (help)
  49. ^ a b Moreno, P. R.; Purushothaman, K. R.; Sirol, M; Levy, A. P.; Fuster, V (2006). "Neovascularization in Human Atherosclerosis". Circulation 113 (18): 2245–52. doi:10.1161/CIRCULATIONAHA.105.578955. PMID 16684874. 
  50. ^ . PMID 19539140.  Missing or empty |title= (help)
  51. ^ "Mission and Vision",SHE Foundation retrieved March 13, 2013
  52. ^ "Meet Dr. Valentin Ruster, Barrio Sesamo's Resident Muppet Doctor", Mount Sinai retrieved March 13, 2013
  53. ^ Fuster, Valentin; Dangas, George; Leon, Martin B.; Smith, Craig; Nesto, Richard; Buse, John B.; Cohen, David J.; Mahoney, Elizabeth; Sleeper, Lynn; King, Spencer; Domanski, Michael; McKinlay, Sonja; Fuster, Valentin (2008). "Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal Management of Multivessel disease (FREEDOM) trial". Am Heart J 51 (11): 215–23. doi:10.1016/j.ahj.2007.10.012. PMID 18215589. 
  54. ^ Fuster, Valentin; Farkouh, M. E. (2010). "General cardiology perspective: decision making regarding revascularization of patients with type 2 diabetes mellitus and cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D)trial". Circulation 8 (121): 2450–2. doi:10.1161/CIRCULATIONAHA.109.925867. PMID 20530023. 
  55. ^ "Bypass surgery significantly better than stents for treating multiple blockages in diabetics" (Press release). Heart.org. November 4, 2012. Retrieved 2013-03-28. 
  56. ^ "Polypill/FOCUS" retrieved March 12, 2013
  57. ^ Fuster V; Kelly, B. B.; Vedanthan, R. (2011). "Promoting global cardiovascular health: moving forward". N Circulation 123 (15): 1671–8. doi:10.1161/CIRCULATIONAHA.110.009522. PMID 21502585. 
  58. ^ Fuster V; Briceño, German; Farkouh, Michael E.; Vedanthan, Rajesh; Baxter, Jorge; Leal, Martha; Boffetta, Paolo; Woodward, Mark; Hunn, Marilyn; Dennis, Rodolfo; Fuster, Valentin (2012). "Targeting preschool children to promote cardiovascular health: cluster randomized trial". N Am J Med 126 (1): 27–35e3. doi:10.1016/j.amjmed.2012.04.045. PMID 23062403. 
  59. ^ Fuster V (2012). "Cardiovascular Risk Surveillance to Develop a Nationwide Health Promotion Strategy: The Grenada Heart Project". Global Heart 7 (2): 87–94. Retrieved April 2, 2013. 
  60. ^ Fuster, Valentin (2007). "Centres of excellence: a Spanish cardiovascular research initiative. Interview by Jennifer Taylor.". Circulation 115 (21): f104–6. PMID 17536248. 
  61. ^ Fuster, Valentin; Torres, Miguel (2012). "CNIC: Achieving Research Excellence Through Collaboration". Rev Esp Cardiol (Engl Ed) 65 (6): 511–6. doi:10.1016/j.recesp.2012.01.008. PMID 22555314. 
  62. ^ Fuster, Valentin; McCall, Carol; Sanz, Javier; Falk, Erling; Fuster, Valentin (2010). "The BioImage Study: Novel Approaches to Risk Assessment in the Primary Prevention of Atherosclerotic Cardiovascular Disease - Study Design and Objectives". Am Heart J 160 (1): 49–57.e1. doi:10.1016/j.ahj.2010.02.021. PMID 20598972. 

External links[edit]